0000899243-23-001798.txt : 20230113
0000899243-23-001798.hdr.sgml : 20230113
20230113172945
ACCESSION NUMBER: 0000899243-23-001798
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230111
FILED AS OF DATE: 20230113
DATE AS OF CHANGE: 20230113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAAB THOMAS R II
CENTRAL INDEX KEY: 0001230708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39473
FILM NUMBER: 23529731
MAIL ADDRESS:
STREET 1: C/O INSPIRE PHARMACEUTICALS, INC.
STREET 2: 4222 EMPEROR BLVD., SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LENSAR, Inc.
CENTRAL INDEX KEY: 0001320350
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 320125724
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2800 DISCOVERY DRIVE
STREET 2: SUITE 100
CITY: ORLANDO
STATE: FL
ZIP: 32826
BUSINESS PHONE: 888-536-7271
MAIL ADDRESS:
STREET 1: 2800 DISCOVERY DRIVE
STREET 2: SUITE 100
CITY: ORLANDO
STATE: FL
ZIP: 32826
FORMER COMPANY:
FORMER CONFORMED NAME: LensAR Inc
DATE OF NAME CHANGE: 20070703
FORMER COMPANY:
FORMER CONFORMED NAME: LaserSoft Vision Inc
DATE OF NAME CHANGE: 20050310
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-11
0
0001320350
LENSAR, Inc.
LNSR
0001230708
STAAB THOMAS R II
C/O LENSAR, INC.
2800 DISCOVERY DRIVE
ORLANDO
FL
32826
0
1
0
0
Chief Financial Officer
Common Stock
2023-01-11
4
A
0
6656
0.00
A
141787
D
Stock Option (Right to Buy)
2.65
2023-01-11
4
A
0
23295
0.00
A
2033-01-11
Common Stock
23295
23295
D
Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in four (4) substantially equal annual installments on each anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
The option vests as to 25% of the award on January 11, 2024 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
/s/ Thomas R. Staab, II
2023-01-13